{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:26:58Z","timestamp":1780338418044,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/s10156-011-0337-8","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T11:31:26Z","timestamp":1320233486000},"page":"324-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Severe pneumococcal community-acquired pneumonia admitted to medical Tunisian ICU"],"prefix":"10.1016","volume":"18","author":[{"given":"Khairallah","family":"Belkhouja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka\u00efs","family":"Ben Romdhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afef","family":"Hammami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalila","family":"Ben Khelil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Besbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Ghariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emna","family":"M\u2019hiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Slim-Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-011-0337-8_bib0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archinte.162.9.1059","article-title":"Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study","volume":"162","author":"Mortensen","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1007\/s10156-011-0337-8_bib0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"10.1007\/s10156-011-0337-8_bib0015","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00134-002-1325-3","article-title":"Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia","volume":"28","author":"Rello","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1007\/s10156-011-0337-8_bib0020","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1378\/chest.07-1456","article-title":"A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU","volume":"133","author":"Restrepo","year":"2008","journal-title":"Chest"},{"key":"10.1007\/s10156-011-0337-8_bib0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.2102084","article-title":"Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria","volume":"166","author":"Angus","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s10156-011-0337-8_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.06.00058605","article-title":"Mixed community-acquired pneumonia in hospitalised patients","volume":"27","author":"De Roux","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1007\/s10156-011-0337-8_bib0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10096-005-1316-8","article-title":"Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia","volume":"24","author":"Van Der Eerden","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-011-0337-8_bib0040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1183\/09031936.04.00119503","article-title":"Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor","volume":"24","author":"Paganin","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1007\/s10156-011-0337-8_bib0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1164\/ajrccm.160.2.9808045","article-title":"Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity","volume":"160","author":"Ruiz","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s10156-011-0337-8_bib0050","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1183\/09031936.03.00064102","article-title":"Community-acquired pneumonia in the elderly: Spanish multicenter study","volume":"21","author":"Zalacain","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1007\/s10156-011-0337-8_bib0055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.123.1.174","article-title":"Microbiological testing and outcome of patients with severe community-acquired pneumonia","volume":"123","author":"Rello","year":"2003","journal-title":"Chest"},{"key":"10.1007\/s10156-011-0337-8_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkf801","article-title":"Global antibiotic resistance in Streptococcus pneumoniae","volume":"50","author":"Adam","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-011-0337-8_bib0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-011-0337-8_bib0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/mdr.1995.1.115","article-title":"Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview","volume":"1","author":"Baquero","year":"1995","journal-title":"Microb Drug Resist"},{"key":"10.1007\/s10156-011-0337-8_bib0075","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.46.5.1295-1301.2002","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000","volume":"46","author":"Low","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-011-0337-8_bib0080","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/420821","article-title":"Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant stains in Asian countries: a study by the Asian network for surveillance of resistant pathogens","volume":"38","author":"Song","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-011-0337-8_bib0085","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1469-0691.2004.00872.x","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: result from five years of the SENTRY Antimicrobial Surveillance Program","volume":"10","author":"Castanheira","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1007\/s10156-011-0337-8_bib0090","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new simplified acute physiology score (SAPS II) based on a European\/North America multicenter study","volume":"270","author":"Le Gall","year":"1993","journal-title":"JAMA"},{"key":"10.1007\/s10156-011-0337-8_bib0095","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1007\/s10156-011-0337-8_bib0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-011-0337-8_bib0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"10.1007\/s10156-011-0337-8_bib0110","series-title":"Performance standards for antimicrobial susceptibility testing: 18th informational supplement. CLSI document M100-S18","year":"2008"},{"key":"10.1007\/s10156-011-0337-8_bib0115","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS: definition, mechanism, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s10156-011-0337-8_bib0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF01720528","article-title":"Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and\/or infection: the ODIN model","volume":"19","author":"Fagon","year":"1993","journal-title":"Intensive Care Med"},{"issue":"suppl 4","key":"10.1007\/s10156-011-0337-8_bib0125","first-page":"IV1","article-title":"BTS guidelines for the management of community acquired pneumonia in adults","volume":"56","year":"2001","journal-title":"Thorax"},{"key":"10.1007\/s10156-011-0337-8_bib0130","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-011-0337-8_bib0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/thx.51.2.179","article-title":"Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one-year prospective study of 346 consecutive patients","volume":"51","author":"Lieberman","year":"1996","journal-title":"Thorax"},{"key":"10.1007\/s10156-011-0337-8_bib0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10096-005-1346-2","article-title":"Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome","volume":"24","author":"Gutierrez","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-011-0337-8_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/mdr.2010.0129","article-title":"Impact of new Clinical Laboratory Standards Institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time","volume":"17","author":"Mera","year":"2011","journal-title":"Microb Drug Resist"},{"key":"10.1007\/s10156-011-0337-8_bib0150","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1183\/09031936.05.00055705","article-title":"Guidelines for the management of adult lower respiratory tract infections","volume":"26","author":"Woodhead","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1007\/s10156-011-0337-8_bib0155","first-page":"235","article-title":"15th consensus conference about management of lower respiratory tract infections in immunocompetent adults","volume":"36","year":"2003","journal-title":"Med Mal Infect"},{"key":"10.1007\/s10156-011-0337-8_bib0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a \u03b2-lactam based empirical regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Martinez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-011-0337-8_bib0165","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s10156-011-0337-8_bib0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005792-200007000-00002","article-title":"Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study","volume":"79","author":"Musher","year":"2000","journal-title":"Medicine (Baltim)"},{"key":"10.1007\/s10156-011-0337-8_bib0175","first-page":"368","article-title":"A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology: results from a Canadian multicenter study","volume":"10","author":"Marrie","year":"2003","journal-title":"Can Respir J"},{"key":"10.1007\/s10156-011-0337-8_bib0180","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.07-1322","article-title":"The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study","volume":"133","author":"Bordon","year":"2008","journal-title":"Chest"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X12703021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X12703021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-011-0337-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:49:32Z","timestamp":1761158972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X12703021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"alternative-id":["S1341321X12703021"],"URL":"https:\/\/doi.org\/10.1007\/s10156-011-0337-8","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe pneumococcal community-acquired pneumonia admitted to medical Tunisian ICU","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-011-0337-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}